Home › Bronchiolitis Obliterans Syndrome › Michigan › Detroit
Bronchiolitis Obliterans Syndrome clinical trials in Detroit, MI
4 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
RecruitingPhase 3
- Henry Ford Hospital, Detroit
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Henry Ford Cancer Institute, Detroit
Bronchiolitis Obliterans Syndrome trials in other cities
- Boston, MA13 studies
- Seattle, WA11 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Baldwin Park, CA6 studies
- Tampa, FL6 studies
- Durham, NC6 studies
- Philadelphia, PA6 studies
- Washington, DC6 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.